{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:26:21Z","timestamp":1794587181654,"version":"4.9.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,19]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Parathyroid carcinoma (PC) is a rare malignant tumor, accounting for &lt;1% of all cases of primary hyperparathyroidism. It is typically characterized by markedly elevated parathyroid hormone (PTH) levels, severe hypercalcemia, and target organ damage. This study presents a single-center experience in the management of patients with PC and provides a review of the relevant literature. The clinical and laboratory data of 8 patients diagnosed with PC based on pathological examination between September 2008 and February 2024 at the Endocrinology Clinic of Akdeniz University Hospital (Antalya, Turkey) were retrospectively reviewed. Eight patients (3 males) were identified, with a median age of 49 years at diagnosis (range: 46\u201371 years) and a median follow-up period of 93 months. All patients presented with hypercalcemia, with a median serum calcium level of 13.39\u2009mg\/dL (range: 11.2\u201319) and a median PTH level of 690 ng\/L (range: 105\u20131625). Organ involvement related to hyperparathyroidism was common, most frequently affecting the kidneys (n\u2005=\u20053) and bones (n\u2005=\u20053). All patients underwent en bloc surgical resection, and 2 received adjuvant radiotherapy. Disease recurrence occurred in 3 patients (37.5%) after a median of 24 months following surgery. The cohort size was insufficient to reliably evaluate predictors of recurrence. The 5-year overall survival and disease-specific survival rates were both 87.5%. PC is characterized by a high recurrence rate and limited treatment options beyond complete surgical excision. The diagnosis should be considered in patients presenting with markedly elevated PTH and calcium levels accompanied by a neck mass. En bloc resection remains the mainstay of treatment. The role of adjuvant radiotherapy remains uncertain and warrants further investigation in larger cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049388","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:00:17Z","timestamp":1782108017000},"page":"e49388","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Parathyroid carcinoma: from diagnostic challenges to surgical management and long-term outcomes: A single-center retrospective analysis"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5145-0920","authenticated-orcid":false,"given":"Mustafa","family":"Aydemir","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Akdeniz University School of Medicine, Antalya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7494-1562","authenticated-orcid":false,"given":"Nusret","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Akdeniz University School of Medicine, Antalya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6989-1492","authenticated-orcid":false,"given":"Ramazan","family":"Sari","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Akdeniz University School of Medicine, Antalya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1912-0240","authenticated-orcid":false,"given":"Cumhur","family":"Arici","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Akdeniz University Faculty of Medicine, Antalya, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261113","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease.","volume":"21","author":"Wermers","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R2-20261113","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11864-011-0171-3","article-title":"Parathyroid carcinoma: update and guidelines for management.","volume":"13","author":"Wei","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"R3-20261113","first-page":"1095","article-title":"Parathyroid carcinoma: the Lahey Clinic experience.","volume":"98","author":"Cohn","year":"1985","journal-title":"Surgery"},{"key":"R4-20261113","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00423-015-1361-4","article-title":"Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.","volume":"401","author":"Ozolins","year":"2016","journal-title":"Langenbecks Arch Surg"},{"key":"R5-20261113","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/BF01665308","article-title":"Diagnosis and treatment of patients with parathyroid carcinoma: an update and review.","volume":"15","author":"Obara","year":"1991","journal-title":"World J Surg"},{"key":"R6-20261113","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0960-7404(99)00037-7","article-title":"Parathyroid cancer: biology and management.","volume":"8","author":"Koea","year":"1999","journal-title":"Surg Oncol"},{"key":"R7-20261113","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<538::AID-CNCR25>3.0.CO;2-K","article-title":"Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society.","volume":"86","author":"Hundahl","year":"1999","journal-title":"Cancer"},{"key":"R8-20261113","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hed.20049","article-title":"Parathyroid carcinoma: a 22-year experience.","volume":"26","author":"Busaidy","year":"2004","journal-title":"Head Neck"},{"key":"R9-20261113","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.hoc.2012.08.009","article-title":"Parathyroid carcinoma: challenges in diagnosis and treatment.","volume":"26","author":"Mohebati","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"R10-20261113","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.clon.2010.04.007","article-title":"Parathyroid carcinoma.","volume":"22","author":"Givi","year":"2010","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R11-20261113","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem.86.2.7207","article-title":"Clinical review 122: parathyroid carcinoma.","volume":"86","author":"Shane","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20261113","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.otc.2004.02.014","article-title":"Parathyroid carcinoma.","volume":"37","author":"Beus","year":"2004","journal-title":"Otolaryngol Clin North Am"},{"key":"R13-20261113","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1210\/edrv-3-2-218","article-title":"Parathyroid carcinoma: a review of 62 patients.","volume":"3","author":"Shane","year":"1982","journal-title":"Endocr Rev"},{"key":"R14-20261113","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0","article-title":"Parathyroid carcinoma. A study of 70 cases.","volume":"31","author":"Schantz","year":"1973","journal-title":"Cancer"},{"key":"R15-20261113","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11864-001-0028-2","article-title":"Parathyroid carcinoma.","volume":"2","author":"Kebebew","year":"2001","journal-title":"Curr Treat Options Oncol"},{"key":"R16-20261113","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12105-009-0115-4","article-title":"Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery.","volume":"3","author":"Wilkins","year":"2009","journal-title":"Head Neck Pathol"},{"key":"R17-20261113","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s42000-020-00220-y","article-title":"Seven cases of parathyroid carcinoma and review of the literature.","volume":"20","author":"Apaydin","year":"2021","journal-title":"Hormones (Athens)"},{"key":"R18-20261113","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00005792-199207000-00002","article-title":"Parathyroid carcinoma: clinical and pathologic features in 43 patients.","volume":"71","author":"Wynne","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"R19-20261113","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3949\/ccjm.60.4.331","article-title":"Parathyroid carcinoma: 50-year experience at the Cleveland Clinic Foundation.","volume":"60","author":"Hakaim","year":"1993","journal-title":"Cleve Clin J Med"},{"key":"R20-20261113","doi-asserted-by":"crossref","first-page":"e92061","DOI":"10.1172\/jci.insight.92061","article-title":"Genomic profiling reveals mutational landscape in parathyroid carcinomas.","volume":"2","author":"Pandya","year":"2017","journal-title":"JCI Insight"},{"key":"R21-20261113","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1359\/jbmr.1999.14.2.230","article-title":"Mapping the gene causing hereditary primary hyperparathyroidism in a Portuguese kindred to chromosome 1q22-q31.","volume":"14","author":"Williamson","year":"1999","journal-title":"J Bone Miner Res"},{"key":"R22-20261113","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"R23-20261113","doi-asserted-by":"crossref","first-page":"E360","DOI":"10.1210\/jc.2014-3238","article-title":"Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion.","volume":"100","author":"Yu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20261113","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12022-011-9151-1","article-title":"Identification of de novo germline mutations in the HRPT2 gene in two apparently sporadic cases with challenging parathyroid tumor diagnoses.","volume":"22","author":"Cavaco","year":"2011","journal-title":"Endocr Pathol"},{"key":"R25-20261113","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1210\/jc.2003-031016","article-title":"Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene.","volume":"89","author":"Cavaco","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20261113","doi-asserted-by":"crossref","first-page":"R229","DOI":"10.1530\/ERC-16-0059","article-title":"Endocrine neoplasms in familial syndromes of hyperparathyroidism.","volume":"23","author":"Li","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"R27-20261113","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-activating mutations in familial isolated hyperparathyroidism.","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"key":"R28-20261113","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3390\/cancers11111676","article-title":"Parathyroid cancer: a review.","volume":"11","author":"Machado","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R29-20261113","doi-asserted-by":"crossref","first-page":"R441","DOI":"10.1530\/ERC-19-0135","article-title":"Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.","volume":"26","author":"Cetani","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"R30-20261113","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/cen.14684","article-title":"Parathyroid carcinoma: single centre experience.","volume":"97","author":"Cunha","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R31-20261113","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3346\/jkms.2012.27.8.890","article-title":"Preoperative predictive factors for parathyroid carcinoma in patients with primary hyperparathyroidism.","volume":"27","author":"Bae","year":"2012","journal-title":"J Korean Med Sci"},{"key":"R32-20261113","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijscr.2017.11.030","article-title":"Parathyroid carcinoma: from a case report to a review of the literature.","volume":"42","author":"Fernandes","year":"2018","journal-title":"Int J Surg Case Rep"},{"key":"R33-20261113","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fendo.2019.00731","article-title":"The clinicopathological spectrum of parathyroid carcinoma.","volume":"10","author":"Akirov","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R34-20261113","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archsurg.136.8.878","article-title":"Localization and reoperation results for persistent and recurrent parathyroid carcinoma.","volume":"136","author":"Kebebew","year":"2001","journal-title":"Arch Surg"},{"key":"R35-20261113","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cncr.20089","article-title":"Parathyroid carcinoma: evaluation and interdisciplinary management.","volume":"100","author":"Clayman","year":"2004","journal-title":"Cancer"},{"key":"R36-20261113","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/cncr.22790","article-title":"Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis?","volume":"110","author":"Fernandez-Ranvier","year":"2007","journal-title":"Cancer"},{"key":"R37-20261113","first-page":"e221","article-title":"Parathyroid cancer cases: a single center\u2019s experience.","volume":"2","author":"Healy","year":"2016","journal-title":"AACE Clin Case Rep"},{"key":"R38-20261113","doi-asserted-by":"crossref","first-page":"229","DOI":"10.15605\/jafes.034.02.17","article-title":"Parathyroid carcinoma: analysis of patient characteristics and outcomes in a retrospective review of eight cases seen in a single center.","volume":"34","author":"Shahar","year":"2019","journal-title":"J ASEAN Fed Endocr Soc"},{"key":"R39-20261113","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijsu.2010.09.003","article-title":"Focus on parathyroid carcinoma.","volume":"9","author":"Kassahun","year":"2011","journal-title":"Int J Surg"},{"key":"R40-20261113","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.pap.0000151319.42376.d4","article-title":"Parathyroid carcinoma: an overview.","volume":"12","author":"DeLellis","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"R41-20261113","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.otc.2010.01.011","article-title":"Parathyroid carcinoma.","volume":"43","author":"Dudney","year":"2010","journal-title":"Otolaryngol Clin North Am"},{"key":"R42-20261113","first-page":"100","article-title":"Parathyroid carcinoma secondary to prolonged hyperplasia in chronic renal failure and in coeliac disease.","volume":"25","author":"Boyle","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"R43-20261113","first-page":"906","article-title":"Parathyroid carcinoma: features and difficulties in diagnosis and management.","volume":"94","author":"Anderson","year":"1983","journal-title":"Surgery"},{"key":"R44-20261113","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EJE-12-0528","article-title":"Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature.","volume":"168","author":"Witteveen","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"R45-20261113","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/0284186X.2017.1306103","article-title":"A nationwide study on parathyroid carcinoma.","volume":"56","author":"Ryh\u00e4nen","year":"2017","journal-title":"Acta Oncol"},{"key":"R46-20261113","doi-asserted-by":"crossref","first-page":"T53","DOI":"10.1530\/ERC-20-0018","article-title":"Hereditary endocrine tumours: current state-of-the-art and research opportunities: new and future perspectives for parathyroid carcinoma.","volume":"27","author":"Perrier","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"R47-20261113","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12902-019-0368-1","article-title":"Current concepts in parathyroid carcinoma: a single centre experience.","volume":"19","author":"Ferraro","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"R48-20261113","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/cen.14161","article-title":"Prognostic role of parafibromin staining and CDC73 mutation in patients with parathyroid carcinoma: a systematic review and meta-analysis based on individual patient data.","volume":"92","author":"Zhu","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R49-20261113","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/js.2018-00043","article-title":"Comprehensive genomic characterization of parathyroid cancer identifies novel candidate driver mutations and core pathways.","volume":"3","author":"Clarke","year":"2019","journal-title":"J Endocr Soc"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:00:33Z","timestamp":1794585633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":49,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049388","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"2024-10-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}